APA (7th ed.) Citation

Dai-Shinozaki, A., Sakakibara-Konishi, J., Hatanaka, K. C., Wakabayashi, K., Shinagawa, N., Matsuno, Y., . . . Konno, S. (2025). Effectiveness of afatinib after long-term gefitinib treatment for EGFR L858R and S768I compound mutation-positive lung adenocarcinoma: A case report. Elsevier.

Chicago Style (17th ed.) Citation

Dai-Shinozaki, Ayuka, Jun Sakakibara-Konishi, Kanako C. Hatanaka, Kento Wakabayashi, Naofumi Shinagawa, Yoshihiro Matsuno, Yutaka Hatanaka, and Satoshi Konno. Effectiveness of Afatinib After Long-term Gefitinib Treatment for EGFR L858R and S768I Compound Mutation-positive Lung Adenocarcinoma: A Case Report. Elsevier, 2025.

MLA (9th ed.) Citation

Dai-Shinozaki, Ayuka, et al. Effectiveness of Afatinib After Long-term Gefitinib Treatment for EGFR L858R and S768I Compound Mutation-positive Lung Adenocarcinoma: A Case Report. Elsevier, 2025.